Literature DB >> 16432153

Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies.

F W van Leeuwen1, P van Tijn, M A F Sonnemans, B Hobo, D M A Mann, C Van Broeckhoven, S Kumar-Singh, P Cras, G Leuba, A Savioz, M L C Maat-Schieman, H Yamaguchi, J M Kros, W Kamphorst, E M Hol, R A I de Vos, D F Fischer.   

Abstract

Frameshift (+1) proteins such as APP(+1) and UBB(+1) accumulate in sporadic cases of Alzheimer disease (AD) and in older subjects with Down syndrome (DS). We investigated whether these proteins also accumulate at an early stage of neuropathogenesis in young DS individuals without neuropathology and in early-onset familial forms of AD (FAD), as well as in other tauopathies, such as Pick disease (PiD) or progressive supranuclear palsy (PSP). APP(+1) is present in many neurons and beaded neurites in very young cases of DS, which suggests that it is axonally transported. In older DS patients (>37 years), a mixed pattern of APP(+1) immunoreactivity was observed in healthy looking neurons and neurites, dystrophic neurites, in association with neuritic plaques, as well as neurofibrillary tangles. UBB(+1) immunoreactivity was exclusively present in AD type of neuropathology. A similar pattern of APP(+1) and UBB(+1) immunoreactivity was also observed for FAD and much less explicit in nondemented controls after the age of 51 years. Furthermore, we observed accumulation of +1 proteins in other types of tauopathies, such as PiD, frontotemporal dementia, PSP and argyrophylic grain disease. These data suggest that accumulation of +1 proteins contributes to the early stages of dementia and plays a pathogenic role in a number of diseases that involve the accumulation of tau.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432153     DOI: 10.1212/01.wnl.0000193882.46003.6d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Nonrandom variations in human cancer ESTs indicate that mRNA heterogeneity increases during carcinogenesis.

Authors:  Marie Brulliard; Dalia Lorphelin; Olivier Collignon; Walter Lorphelin; Benoit Thouvenot; Emmanuel Gothié; Sandrine Jacquenet; Virginie Ogier; Olivier Roitel; Jean-Marie Monnez; Pierre Vallois; Frances T Yen; Olivier Poch; Marc Guenneugues; Gilles Karcher; Pierre Oudet; Bernard E Bihain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

Review 2.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Authors:  Ashok N Hegde; Sudarshan C Upadhya
Journal:  Biochim Biophys Acta       Date:  2010-08-03

3.  Transcriptional frameshifts contribute to protein allergenicity.

Authors:  Benoit Thouvenot; Olivier Roitel; Julie Tomasina; Benoit Hilselberger; Christelle Richard; Sandrine Jacquenet; Françoise Codreanu-Morel; Martine Morisset; Gisèle Kanny; Etienne Beaudouin; Christine Delebarre-Sauvage; Thierry Olivry; Claude Favrot; Bernard E Bihain
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 4.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 5.  The potential role of ribosomal frameshifting in generating aberrant proteins implicated in neurodegenerative diseases.

Authors:  Norma M Wills; John F Atkins
Journal:  RNA       Date:  2006-05-18       Impact factor: 4.942

6.  Isolation and characterization of RNA polymerase rpoB mutations that alter transcription slippage during elongation in Escherichia coli.

Authors:  Yan Ning Zhou; Lucyna Lubkowska; Monica Hui; Carolyn Court; Shuo Chen; Donald L Court; Jeffrey Strathern; Ding Jun Jin; Mikhail Kashlev
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

7.  Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.

Authors:  Martin Irmler; Romina J G Gentier; Frank J A Dennissen; Holger Schulz; Ines Bolle; Sabine M Hölter; Magdalena Kallnik; Jing Jun Cheng; Martin Klingenspor; Jan Rozman; Nicole Ehrhardt; Denise J H P Hermes; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Helmut E Meyer; David A Hopkins; Fred W Van Leeuwen; Johannes Beckers
Journal:  Acta Neuropathol       Date:  2012-06-23       Impact factor: 17.088

8.  What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population?

Authors:  Robyn A Wallace; Arthur J Dalton
Journal:  Alzheimers Res Ther       Date:  2011-04-19       Impact factor: 6.982

Review 9.  Prion degradation pathways: Potential for therapeutic intervention.

Authors:  Rob Goold; Chris McKinnon; Sarah J Tabrizi
Journal:  Mol Cell Neurosci       Date:  2015-01-10       Impact factor: 4.314

Review 10.  Role of the ubiquitin proteasome system in Alzheimer's disease.

Authors:  Sudarshan C Upadhya; Ashok N Hegde
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.